# Genebox

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/genebox

- Industry: Biotechnology
- Headquarters: Beijing, China
- Website: www.genebox.cn/
- Latest round: Series B (Jul 1, 2026)
- Investors on record: 2

## About

Based in Beijing, China and established in 2018, Beijing Lasuo Biotechnology Co., Ltd., trading as Genebox, is a solid-phase chip technology developer. In July 2026, Genebox raised a series B+ funding from Guizhou Venture Capital and Zhaoken Capital Management (Beijing).

The company is primarily engaged in the research, development, production, and commercialization of integrated solid-phase gene chip solutions encompassing customizable chips, scanning equipment, reagents, algorithms, and supporting software. It has established a product matrix covering major livestock and poultry and key crops, continuously empowering genomic selection and efficient breeding.

The company's revenue is generated by providing integrated solid-phase gene chip solutions encompassing customizable chips, scanning equipment, reagents, algorithms, and supporting software.

## Funding rounds

- Series B, Jul 1, 2026 — Guizhou Venture Capital, Zhaoken Capital Management (Beijing)

## Investors

- Guizhou Venture Capital (https://capitalatlas.ai/funds/guizhou-venture-capital) — Series B
- Zhaoken Capital Management (Beijing) (https://capitalatlas.ai/funds/zhaoken-capital-management-beijing) — Series B